中国胸外科围手术期气道管理指南(2020版)

2021-01-13 中国胸心血管外科临床杂志.2021.28(3):1-12.

患者术前至少戒烟 4 周、需进行肺功能评估和肺康复训练,尤其是合并高危因素的患者至少肺康复训练 1 周;术中麻醉维持采用吸入或静脉麻醉,推荐选择短效药物,使用麻醉深度和肌肉松驰深度监测,推荐保护性通气

中文标题:

中国胸外科围手术期气道管理指南(2020版)

发布机构:

发布日期:

2021-01-13

简要介绍:

患者术前至少戒烟 4 周、需进行肺功能评估和肺康复训练,尤其是合并高危因素的患者至少肺康复训练 1 周;术中麻醉维持采用吸入或静脉麻醉,推荐选择短效药物,使用麻醉深度和肌肉松驰深度监测,推荐保护性通气策略;术后使用药物和机械性措施预防静脉血栓栓塞症,合理应用各种引流管,疼痛管理则推荐采用预镇痛、多模式镇痛;围手术期可使用吸入性糖皮质激素联合支气管扩张剂治疗,从而降低气道高反应性、缓解术后咳嗽。结论 胸外科围手术期气道管理术前强调戒烟、肺功能评估及肺康复训练;术中强调麻醉药物合理应用和肺保护性通气策略;术后加强气道管理、疼痛管理和引流管管理,同时重视术后咳嗽评估与处理。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国胸外科围手术期气道管理指南_2020版_支修益.pdf)] GetToolGuiderByIdResponse(projectId=1, id=55cd81c00203ea0e, title=中国胸外科围手术期气道管理指南(2020版), enTitle=, guiderFrom=中国胸心血管外科临床杂志.2021.28(3):1-12., authorId=0, author=, summary=患者术前至少戒烟 4 周、需进行肺功能评估和肺康复训练,尤其是合并高危因素的患者至少肺康复训练 1 周;术中麻醉维持采用吸入或静脉麻醉,推荐选择短效药物,使用麻醉深度和肌肉松驰深度监测,推荐保护性通气, cover=https://img.medsci.cn/2021118/1610984024284_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Jan 13 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>患者术前至少戒烟 4 周、需进行肺功能评估和肺康复训练,尤其是合并高危因素的患者至少肺康复训练 1 周;术中麻醉维持采用吸入或静脉麻醉,推荐选择短效药物,使用麻醉深度和肌肉松驰深度监测,推荐保护性通气策略;术后使用药物和机械性措施预防静脉血栓栓塞症,合理应用各种引流管,疼痛管理则推荐采用预镇痛、多模式镇痛;围手术期可使用吸入性糖皮质激素联合支气管扩张剂治疗,从而降低气道高反应性、缓解术后咳嗽。结论 胸外科围手术期气道管理术前强调戒烟、肺功能评估及肺康复训练;术中强调麻醉药物合理应用和肺保护性通气策略;术后加强气道管理、疼痛管理和引流管管理,同时重视术后咳嗽评估与处理。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=800, tagName=围手术期)], categoryList=[CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=800, guiderKeyword=围手术期, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10034, appHits=440, showAppHits=0, pcHits=1455, showPcHits=9593, likes=3, shares=41, comments=21, approvalStatus=1, publishedTime=Tue Jan 19 00:12:33 CST 2021, publishedTimeString=2021-01-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Jan 18 23:33:54 CST 2021, updatedBy=6415643, updatedName=凯晨, updatedTime=Sat Jan 06 22:26:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国胸外科围手术期气道管理指南_2020版_支修益.pdf)])
中国胸外科围手术期气道管理指南_2020版_支修益.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200190, encodeId=b121120019015, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e753000202, createdName=63718310, createdTime=Mon Mar 07 11:02:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182890, encodeId=14a81182890d4, content=系统学习中,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b9a1569376, createdName=liuyan8586, createdTime=Mon Jan 10 16:59:43 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068141, encodeId=11601068141b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Mon Nov 08 15:50:02 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051038, encodeId=aff51051038bb, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/2c3f9f8b19144a3f86fe6d813c87c989/a219d3f981754d0a92a57c4aaaccb37c.jpg, createdBy=fce45439300, createdName=沉和, createdTime=Tue Sep 14 10:34:37 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011503, encodeId=60a5101150338, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a355585152, createdName=ms4000002010470802, createdTime=Wed Aug 25 21:55:20 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2022-03-07 63718310

    学习,学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200190, encodeId=b121120019015, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e753000202, createdName=63718310, createdTime=Mon Mar 07 11:02:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182890, encodeId=14a81182890d4, content=系统学习中,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b9a1569376, createdName=liuyan8586, createdTime=Mon Jan 10 16:59:43 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068141, encodeId=11601068141b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Mon Nov 08 15:50:02 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051038, encodeId=aff51051038bb, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/2c3f9f8b19144a3f86fe6d813c87c989/a219d3f981754d0a92a57c4aaaccb37c.jpg, createdBy=fce45439300, createdName=沉和, createdTime=Tue Sep 14 10:34:37 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011503, encodeId=60a5101150338, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a355585152, createdName=ms4000002010470802, createdTime=Wed Aug 25 21:55:20 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2022-01-10 liuyan8586

    系统学习中,感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200190, encodeId=b121120019015, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e753000202, createdName=63718310, createdTime=Mon Mar 07 11:02:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182890, encodeId=14a81182890d4, content=系统学习中,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b9a1569376, createdName=liuyan8586, createdTime=Mon Jan 10 16:59:43 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068141, encodeId=11601068141b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Mon Nov 08 15:50:02 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051038, encodeId=aff51051038bb, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/2c3f9f8b19144a3f86fe6d813c87c989/a219d3f981754d0a92a57c4aaaccb37c.jpg, createdBy=fce45439300, createdName=沉和, createdTime=Tue Sep 14 10:34:37 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011503, encodeId=60a5101150338, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a355585152, createdName=ms4000002010470802, createdTime=Wed Aug 25 21:55:20 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-11-08 ms1000000237784199

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1200190, encodeId=b121120019015, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e753000202, createdName=63718310, createdTime=Mon Mar 07 11:02:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182890, encodeId=14a81182890d4, content=系统学习中,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b9a1569376, createdName=liuyan8586, createdTime=Mon Jan 10 16:59:43 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068141, encodeId=11601068141b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Mon Nov 08 15:50:02 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051038, encodeId=aff51051038bb, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/2c3f9f8b19144a3f86fe6d813c87c989/a219d3f981754d0a92a57c4aaaccb37c.jpg, createdBy=fce45439300, createdName=沉和, createdTime=Tue Sep 14 10:34:37 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011503, encodeId=60a5101150338, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a355585152, createdName=ms4000002010470802, createdTime=Wed Aug 25 21:55:20 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-09-14 沉和

    有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1200190, encodeId=b121120019015, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e753000202, createdName=63718310, createdTime=Mon Mar 07 11:02:13 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182890, encodeId=14a81182890d4, content=系统学习中,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b9a1569376, createdName=liuyan8586, createdTime=Mon Jan 10 16:59:43 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068141, encodeId=11601068141b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Mon Nov 08 15:50:02 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051038, encodeId=aff51051038bb, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210914/2c3f9f8b19144a3f86fe6d813c87c989/a219d3f981754d0a92a57c4aaaccb37c.jpg, createdBy=fce45439300, createdName=沉和, createdTime=Tue Sep 14 10:34:37 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011503, encodeId=60a5101150338, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a355585152, createdName=ms4000002010470802, createdTime=Wed Aug 25 21:55:20 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-08-25 ms4000002010470802

    没积分了

    0